United Kingdom· GB-APID-3641211000001108

Doublebase gel

A medicinal product containing liquid paraffin + isopropyl myristate, registered in United Kingdom by Dermal Laboratories Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDoublebase gelATC—REGISTER NO.GB-APID-3641211000001…PACKS LISTED3CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Liquid paraffin + Isopropyl myristate
Manufacturer
Dermal Laboratories Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5016379191008
  • gtin
    5016379190001
  • gtin
    5016379192005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/150a3053-38da-4390-acad-b8d1d7ba8420
GET /v1/drugs/150a3053-38da-4390-acad-b8d1d7ba8420?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3641211000001108",
  "desc": "Doublebase gel (Dermal Laboratories Ltd)",
  "form": "Cutaneous gel",
  "vpid": "3655311000001100",
  "source": "dmd",
  "vtm_id": "776424009",
  "strength": "150 mg",
  "substance": "Liquid paraffin + Isopropyl myristate",
  "ingredient": "Isopropyl myristate",
  "supplier_code": "3146001000001107"
}

See everything about liquid paraffin + isopropyl myristate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.